GIP
Selected indexed studies
- GIP and GLP-1, the two incretin hormones: Similarities and differences. (J Diabetes Investig, 2010) [PMID:24843404]
- The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update. (Diabetes Obes Metab, 2021) [PMID:34310013]
- GIP analogues and the treatment of obesity-diabetes. (Peptides, 2020) [PMID:31756366]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- GIP and GLP-1, the two incretin hormones: Similarities and differences. (2010) pubmed
- The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update. (2021) pubmed
- GIP analogues and the treatment of obesity-diabetes. (2020) pubmed
- GIP's involvement in the pathophysiology of type 2 diabetes. (2020) pubmed
- Physiology and clinical applications of GIP. (2025) pubmed
- GIP and the gut-bone axis - Physiological, pathophysiological and potential therapeutic implications. (2020) pubmed
- Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease. (2020) pubmed
- Molecular evolution of GIP and Exendin and their receptors. (2020) pubmed
- Recent advances of GIP and future horizons. (2020) pubmed
- GIP(3-30)NH(2) - a tool for the study of GIP physiology. (2020) pubmed